Filing Details
- Accession Number:
- 0001415889-23-013137
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-11 09:15:13
- Reporting Period:
- 2023-08-30
- Accepted Time:
- 2023-09-11 09:15:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1719406 | Nrx Pharmaceuticals Inc. | NRXP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1630542 | Chaim Hurvitz | C/O Nrx Pharmaceuticals, Inc. 1201 North Market Street, Suite 111 Wilmington DE 19801 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2023-08-30 | 70,000 | $0.29 | 570,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | 1,436,350 | Indirect | By Shirat HaChaim Ltd. |
| Common Stock, Par Value $0.001 Per Share | 208,443 | Indirect | By CH Health-Private Venture Capital Ltd. |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions. TheReporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.
- Chaim Hurwitz is the owner of Shirat HaChaim Ltd.
- Chaim Hurwitz is the owner of CH Health-Private Venture Capital Ltd.
Billionaire Hedge Funds
